All 1 tracked stories fall under one category: pharma. Washington State is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. Jay Inslee appears in 1 tracked Biotech story from March 16, 2026. The tracked stories average 2 original sources each.
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about Jay Inslee
All 1 tracked stories fall under one category: pharma. Washington State is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. Jay Inslee appears in 1 tracked Biotech story from March 16, 2026. The tracked stories average 2 original sources each.
Stories tracked
1
Sources per story
2
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 13 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering Jay Inslee. Shared-story counts are live from our verified record — not editorial picks.
Washington Governor has signed legislation authorizing the state to distribute its 30,000-dose stockpile of mifepristone to private and non-profit healthcare providers. The law resolves previous licensing hurdles that prevented the state's Department of Corrections from acting as a wholesale distributor for reproductive health medications.
Jay Inslee is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source
link? Report a data issue.